Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Retinoblastoma 1 Recurrence 1 Neoplasms, Germ Cell and Embryonal 1

Interventions

Etoposide 7 Cisplatin 7 fludarabine 4 Cyclophosphamide 4 fludarabine phosphate 3 Paclitaxel 3 Carboplatin 3 Bleomycin 3 Automobiles 3 pembrolizumab 2 etoposide phosphate 2 Vorinostat 2 Sirolimus 2 Mesna 2 Ifosfamide 2 Drug Therapy 2 130-nm albumin-bound paclitaxel 2 tremelimumab 1 sodium thiosulfate 1 repotrectinib 1 pralsetinib 1 pegfilgrastim 1 lutetium Lu 177 dotatate 1 durvalumab 1 cabozantinib 1 Watchful Waiting 1 Teniposide 1 Surveys and Questionnaires 1 Stem Cell Transplantation 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms, Germ Cell and Embryonal × Cytapheresis × 1 year × Clear all

NCT00864318 2026-04-14

TICE

Institut Claudius Regaud

Phase 2 Completed

Neoplasms, Germ Cell and Embryonal, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡